The capability/approval gap for AI mental-health chatbots is being closed by litigation, not evidence: Slingshot pulled Ash from the UK (no reg pathway), PA is suing Character.AI (posing as doctors; 5-family suicide settlement), FDA advisers say regulation is needed (none approved), 10+ wrongful-death suits. Track the first real regulatory pathway (FDA/MHRA), case outcomes, and any big-tech health-arm move into the vacuum. Ben's sharpest edge — the evidence-gap thesis playing out live.
Summary
Maine's AI-therapy statute became the first in the nation to actually take effect, as litigation and state law fill the gap where federal approval does not exist.
Whether a real regulatory pathway emerges to replace ad hoc litigation as the way AI mental-health harms get addressed is the open question.

